Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension

Abstract Background Dapagliflozin, a selective inhibitor of sodium-glucose cotransporter 2 (SGLT2), can reduce cardiovascular events and mortality in patients with heart failure. A number of mechanisms have been proposed to explain the beneficial effects of SGLT2 inhibitors. The purpose of this stud...

Descripción completa

Detalles Bibliográficos

Autores principales:	Yi Tang, Siyuan Tan, Minqi Li, Yijin Tang, Xiaoping Xu, Qinghai Zhang, Qinghua Fu, Mingxiang Tang, Jin He, Yi Zhang, Zhaofen Zheng, Jianqiang Peng, Tengteng Zhu, Wenlin Xie
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2022-04-01
Colección:	BMC Pulmonary Medicine
Materias:	Dapagliflozin Sildenafil Pulmonary arterial hypertension
Acceso en línea:	https://doi.org/10.1186/s12890-022-01939-7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!